僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Rosopatamab （HuJ591） is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 （177Lu） through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency